GlassScriptPhysician profile
Carlos Ayala
NPI 1881688174
$3,880.21
in general payments reported to CMS, 2019-2025
19 companies · $737 in 2025
The $737 reported for 2025 was more than what 75% of Otolaryngology/Facial Plastic Surgery providers received nationally (typical 2025 total: $305).
See the full distribution for Otolaryngology/Facial Plastic Surgery
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,712 · 2020: $40.47 · 2021: $87.33 · 2022: $207 · 2023: $353 · 2024: $743 · 2025: $737.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,833.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,833.03 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medical Device Business Services, INC. | $1,005.77 | 2019 | |
| Medtronic, INC. | $632.72 | 2021-2025 | Propel, Stealthstation S8 Platform, Nuvent |
| Acclarent, INC | $422.93 | 2019-2022 | |
| Optinose US, INC. | $298.99 | 2021-2024 | |
| Regeneron Healthcare Solutions, INC. | $245.18 | 2023-2025 | Dupixent |
| Galderma Laboratories, L.P. | $202.61 | 2019-2025 | |
| Tei Biosciences INC | $180.95 | 2019 | |
| Integra Lifesciences Corporation | $158.82 | 2024 | Integra, Integra Dermal Regeneration Template, Omnigraft |
| Genzyme Corporation | $139.53 | 2019-2025 | |
| Revance Therapeutics, INC. | $117.13 | 2025 | Daxxify |
| Coherus Oncology, INC. | $110.00 | 2025 | Loqtorzi |
| Phadia US INC. | $97.55 | 2019-2025 | Immunocap |
| Allergan, INC. | $95.75 | 2022 | |
| Medtronic USA, INC. | $82.28 | 2019-2020 | |
| Intersect Ent, INC. | $24.87 | 2021 |
Show all 19 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Pbg Puerto Rico LLC | $19.07 | 2025 | |
| Apyx Medical Corporation | $17.01 | 2019 | |
| Aerin Medical INC. | $16.96 | 2023 | |
| Sanofi-Aventis U.S. LLC | $12.09 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Carlos Ayala listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.